CClinicalTrials.gg
Not yet recruitingNCT07344740Updated Feb 13, 2026

Blood Flow Restriction Resistance Exercise and Cardiac Cycle Dynamics

An interventional study of Blood flow restriction resistance exercise in Cardiac, sponsored by Montclair State University. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-13.

Sponsored by Montclair State University · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Not applicable
Ages
18 Years to 50 Years
Sex
All
01

Study summary

Blood flow restriction resistance exercise uses partial vascular occlusion of a limb during low weight resistance exercises to stimulate muscle strengthening and growth. This is commonly used during rehabilitation from an injury. Because blood flow in and out of the limbs is decreased, this may have consequences for blood flow through the heart. The purpose of this study will be to test cardiac dynamics during blood flow restriction resistance exercise to determine if cardiac blood flow is impacted. It is hypothesized that both non-BFR exercise and BFR exercise will increase heart rate shortening various cardiac cycle parameters, but BFR exercise will increase the isovolumetric contraction time vs non-BFR exercise due to an increase in total peripheral resistance. It is also hypothesized that BFR exercise will lower early ventricular filling parameters due to lower venous return.

02

Conditions studied

  • Cardiac
03

In context

Lead sponsor

Montclair State University is the lead sponsor of 13 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Generally healthy

Exclusion criteria

Exclusion Criteria:

  • Uncontrolled hypertension
  • Peripheral vascular disease
  • Lymphedema
  • Sickle cell anemia
  • Heart failure
  • Stroke history
  • Heart attack history
  • Rheumatoid arthritis
  • Chronic kidney disease
  • Diabetes
  • Severe neuropathy
  • Any condition that may make blood flow restriction resistance exercise riskier like history of blood clots
  • Use of coagulant therapy
  • Susceptible to blood clots
  • Obesity
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Intervention group

    Blood flow restriction resistance exercise

    Behavioral: Blood flow restriction resistance exercise

Interventions

  • BehavioralBlood flow restriction resistance exercise

    Blood flow in and out of the limb will be artificially with an occlusion cuff.

06

What researchers measure

Primary outcomes

  1. Cardiac cycle durations

    Time frame: During the intervention for approximately 10 minutes.

  2. Ventricular filling

    Time frame: During intervention phase for approximately 10 minutes.

07

Study locations

1 site
  • Montclair State University
    Montclair, New Jersey 07043, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 13, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07344740
Lead sponsor
Montclair State University
Responsible party
Sponsor
First posted
Jan 15, 2026
Start date
Feb 1, 2026 (estimated)
Primary completion
Jan 1, 2028 (estimated)
Completion
Jan 1, 2028 (estimated)
Last update
Feb 13, 2026

Study contacts

Evan Matthews
Contact
matthewse@montclair.edu
17406328709

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion